Toxicon : official journal of the International Society on Toxinology · 2025
Antinociceptive and neuromodulatory effects of the scorpion venom tetrapeptide tetrascorpin-1 in a long-lasting pain hypersensitivity model in mice.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pagano Salvatore, Limongelli Rebecca, Moslah Wassim, Saada Mohamed-Chiheb, Manzo Iolanda, Bonsale Roozbe, Teweldemedhin Milena Melake, Fusco Antimo, Guida Francesca, Belardo Carmela, Morace Andrea Maria, Perrone Michela, Ricciardi Federica, Pierretti Gorizio, Vastarella Maria Giovanna, Infantino Rosmara, Srairi-Abid Najet, Maione Sabatino, Palazzo Enza, Luongo Livio
Аннотация
We evaluated the effects of Tetrascorpin-1 from Androctonus australis (AaTs-1), a tetrapeptide obtained from scorpion venom, previously hypothesized to bind the formyl peptide receptor like-1 (FPRL-1) known as formyl peptide receptor-2 (FPR-2) in vitro, on pain responses and cytokines, neuronal and glial morpho-functional alterations in the spinal cord of mice with formalin-induced long-lasting pain hypersensitivity. Due to the peptide chemical nature and for favoring its penetration into the central nervous system, AaTs-1 was daily administered intranasally for 10 days. In formalin-injected mice the AaTs-1 treatment abolished mechanical allodynia, thermal hyperalgesia, hyperactivation of spinal nociceptive-specific (NS) neurons, and partially restored spinal anti-inflammatory/pro-inflammatory cytokine levels and microglia/astrocyte phenotype alterations. Additionally, in contrast to what occurred in formalin-injected mice, AaTs-1 treatment facilitated the firing activity of NS neurons and consistently altered the levels of some spinal cytokines under investigation in healthy mice. Based on the opposing effects of AaTs-1 under physiological and pathological conditions, we suspect that it acts as a partial agonist in vivo rather than as an antagonist of FPR-2, as other in vitro data would suggest.